Dalhousie's medical marijuana study to evaluate effect on arthritis

Warning message

The subscription service is currently unavailable. Please try again later.

A study evaluating the effect of medical marijuana on arthritis is recruiting patients in Halifax and Montreal. 

The Dalhousie University study will be the first to measure the effect of vaporized cannabis with different amounts of cannabinoids.

Dr. Mary Lynch is leading the study. 

"It's helping us to move forward in identifying what are the best products that are going to be the most help, causing the fewest side effects," she says.

Patients aged 50 or older with osteoarthritis knee pain in Halifax and Montreal will be given several doses of vaporized medical marijuana with varying amounts of THC and CBD.

CBD is a non-psychoactive agent found in cannabis, while THC is a psychoactive agent. Researchers hope CBD will be able to fight pain without the side effect of getting high. 

The study will be double-blind, with a control placebo. Neither participants nor researchers will know which participants are taking the real plant and which placebos. ...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.cbc.ca/news/canada/nova-scotia/dalhousie-s-medical-marijuana-study-to-evaluate-effect-on-arthritis-1.3126098